RecruitingNot ApplicableNCT06964867

Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters


Sponsor

Changzhou No.2 People's Hospital

Enrollment

300 participants

Start Date

Dec 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The patients with vitreous floaters were randomly divided into to groups after excluding the possibility of coexisting ocular pathologies potentially confounding visual symptoms or vitreoretinal anatomy. The control group performed conventional oral education. The experimental group conducted multimedia health education activities on the basis of conventional oral education. Their VRQoL (Visual Function Questionnaire-25, VFQ-25) and anxiety status (State-Trait Anxiety Inventory, STAI) were evaluated before education and at the final follow-up. The demographic and clinical characteristics (gender, age, eduaction, duration of vitreous floaters, comorbidities and so on) were collected.


Eligibility

Inclusion Criteria2

  • Clinical diagnosis of vitreous floaters;
  • Be able to complete questionnaires.

Exclusion Criteria3

  • Secondary VF requiring surgical intervention;
  • Coexisting ocular pathologies potentially confounding vitreoretinal anatomy;
  • History of vitreoretinal surgery.

Interventions

OTHERMultimedia Health Education

Multimedia health education was designed as an intervention. This intervention was administered by a single vitreoretinal specialist with over a decade of clinical experience. This standardized protocol comprised a 30-minute didactic session utilizing power point presentations (PPT), systematically covering: 1) Etiopathogenesis: Molecular mechanisms of vitreous syneresis and collagen aggregation; 2) Symptomatology: Characteristic visual phenomena and differential diagnosis; 3) Therapeutic modalities: Evidence hierarchy from observation to vitrectomy (including Nd:YAG laser efficacy controversies); 4) Follow-up necessity: Red flag symptoms warranting urgent re-evaluation (sudden floaters with photopsia)


Locations(1)

the Second People's Hospital of Changzhou

Changzhou, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06964867


Related Trials